Genflow Biosciences PLC Announces Result of GM
Accessnewswire·2026-03-02 12:55
Core Viewpoint - Genflow Biosciences Plc, a leading European biotechnology company focused on longevity, successfully passed all resolutions proposed at its General Meeting held on March 2, 2026 [1] Summary by Relevant Categories - Company Performance - All resolutions proposed at the General Meeting were duly passed by shareholders, indicating strong support for the company's strategic direction [1] - Shareholder Engagement - The number of proxy votes for each resolution submitted prior to the meeting was presented, reflecting active shareholder participation in corporate governance [1]